Lupus Trial, Recruiting
Who may be able to join
AI generated eligibility summary. Written by an AI model from the official source data and checked on a sample basis. It can contain mistakes, so confirm anything important against the original source. How we use AI
Who might be able to join this trial:
- People who have been diagnosed through a biopsy with a specific type of lupus-related kidney disease (called Class III, IV, or V lupus nephritis), and who are currently showing signs of active kidney inflammation, such as significantly increased protein in their urine or a notable decline in kidney function compared to their previous baseline levels.
- People who are willing to give their consent to participate in the trial.
Who may not be able to join:
- People who have taken certain immune-suppressing medications known as calcineurin inhibitors or proliferation signal inhibitors (confirm with trial site for specific drug names) within the past 3 months.
- People who have received a type of treatment called biologic therapy — for example, rituximab or abatacept — within the past 12 months.
- People who are currently pregnant or breastfeeding.
Important: Always verify eligibility with the trial site directly before applying.
Based on publicly available eligibility criteria from ClinicalTrials.gov. Verify directly with the trial site before acting. This is not medical advice.
Contact this trial
Phone: 22554385
Contact details sourced from ClinicalTrials.gov. Verify directly with the trial site before attending.
GP referral letter
Print a one-page summary to share with your doctor.
Trial details
Where this trial is recruiting
Primary endpoints
Lymphocyte subset profile (CD8+ T cells, CD4+ Th1, Th2, Th17 & Treg), Naïve & memory B cells, plasma cells
Can't join this trial?
Data last synced from ClinicalTrials.gov: 28 July 2026. Trial status can change. Always verify current status directly with the trial site before making any decision.